| Ticker Details |
|
MIRUM PHARMACEUTICALS, INC.
|
| IPO Date: |
July 12, 2019 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$6.01B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.71 | 2.51%
|
| Avg Daily Range (30 D): |
$2.46 | 2.48%
|
| Avg Daily Range (90 D): |
$1.82 | 1.88%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.31M |
| Avg Daily Volume (30 D): |
.84M |
| Avg Daily Volume (90 D): |
.7M |
| Trade Size |
| Avg Trade Size (Sh.): |
58 |
| Avg Trade Size (Sh.) (30 D): |
62 |
| Avg Trade Size (Sh.) (90 D): |
52 |
| Institutional Trades |
| Total Institutional Trades: |
2,288 |
| Avg Institutional Trade: |
$3.44M |
| Avg Institutional Trade (30 D): |
$6.17M |
| Avg Institutional Trade (90 D): |
$6.9M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.18M |
| Avg Closing Trade (30 D): |
$9.86M |
| Avg Closing Trade (90 D): |
$12.9M |
| Avg Closing Volume: |
88.72K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-13.61
|
$-13.43
|
$-.12
|
|
Diluted EPS
|
$-13.62
|
$-13.43
|
$-.12
|
|
Revenue
|
$569.61M
|
$159.88M
|
$148.93M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-798.84M
|
$-790.16M
|
$-5.73M
|
|
Operating Income / Loss
|
$-796.42M
|
$-789.47M
|
$-4.57M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$113.5M
|
$29.75M
|
$16.07M
|
|
PE Ratio
|
|
|
|
|
|
|